ATE239722T1 - Benzofurylpiperazine als serotonin-agonisten - Google Patents

Benzofurylpiperazine als serotonin-agonisten

Info

Publication number
ATE239722T1
ATE239722T1 AT00948746T AT00948746T ATE239722T1 AT E239722 T1 ATE239722 T1 AT E239722T1 AT 00948746 T AT00948746 T AT 00948746T AT 00948746 T AT00948746 T AT 00948746T AT E239722 T1 ATE239722 T1 AT E239722T1
Authority
AT
Austria
Prior art keywords
benzofurylpiperazine
serotonin agonists
serotonin
agonists
benzofurans
Prior art date
Application number
AT00948746T
Other languages
English (en)
Inventor
Karin Briner
Timothy Paul Burkholder
Mark Louis Heiman
David Lloyd Garver Nelson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE239722T1 publication Critical patent/ATE239722T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00948746T 1999-07-29 2000-07-21 Benzofurylpiperazine als serotonin-agonisten ATE239722T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14628799P 1999-07-29 1999-07-29
US17216999P 1999-12-17 1999-12-17
PCT/US2000/019545 WO2001009123A1 (en) 1999-07-29 2000-07-21 Benzofurylpiperazine serotonin agonists

Publications (1)

Publication Number Publication Date
ATE239722T1 true ATE239722T1 (de) 2003-05-15

Family

ID=26843756

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00948746T ATE239722T1 (de) 1999-07-29 2000-07-21 Benzofurylpiperazine als serotonin-agonisten

Country Status (11)

Country Link
US (1) US6638936B1 (de)
EP (1) EP1204658B1 (de)
JP (1) JP2003506370A (de)
AT (1) ATE239722T1 (de)
AU (1) AU6220300A (de)
CA (1) CA2380531A1 (de)
DE (1) DE60002583T2 (de)
DK (1) DK1204658T3 (de)
ES (1) ES2198329T3 (de)
PT (1) PT1204658E (de)
WO (1) WO2001009123A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60004066T2 (de) * 1999-07-29 2004-04-15 Eli Lilly And Co., Indianapolis Benzofurylpiperazine: 5-ht2c serotoninrezeptor agonisten
EP1337518B1 (de) 2000-11-20 2009-06-17 Biovitrum AB (publ) Piperazinylpyrazinverbindungen als antagonisten des serotonin-5-ht2-rezeptors
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
DK1408976T5 (da) * 2001-07-20 2011-01-10 Psychogenics Inc Behandling af ADHD (Attention deficit hyperactivity disorder)
BR0311970A (pt) 2002-06-19 2005-03-29 Biovitrum Ab Novos compostos, seu uso e preparação
US8685924B2 (en) 2004-08-25 2014-04-01 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
EP2018863B9 (de) 2006-05-16 2015-02-18 Takeda Pharmaceutical Company Limited Kondensierte, heterocyclische Verbindung und ihre Verwendung
WO2008052086A1 (en) * 2006-10-24 2008-05-02 Wyeth Benzodioxane derivatives and uses thereof
EP2789338A3 (de) 2007-11-15 2015-01-14 Takeda Pharmaceutical Company Limited Kondensiertes Pyridinderivat und seine Verwendung
US20120253036A1 (en) 2009-12-11 2012-10-04 Yukinori Nagakura Agent for treating fibromyalgia
WO2015066344A1 (en) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists and compositions and methods of use
US20210052600A1 (en) 2017-12-27 2021-02-25 Takeda Pharmaceutical Company Limited Therapeutic agents for stress urinary incontinence and incotinence of feces
CN112773898A (zh) * 2019-11-11 2021-05-11 广州华真医药科技有限公司 磷酸二酯酶5抑制剂在制备抗纤维化疾病药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006524A1 (de) * 1978-06-22 1980-01-09 Ciba-Geigy Ag Neue Tetrahydropyridin- und Piperidinderivate und deren Säureadditionssalze, Verfahren zu deren Herstellung und solche enthaltende pharmazeutische Zusammensetzungen
DE3586794T2 (de) * 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
EP0724580A1 (de) * 1993-10-19 1996-08-07 Smithkline Beecham Plc Benzamilid-derivate als 5ht-1d-rezeptor antagonisten
US5698766A (en) * 1995-04-05 1997-12-16 The Regents Of The University Of California Transgenic animal model for testing drugs for treating eating disorders and epilepsy
GB9517559D0 (en) 1995-08-26 1995-10-25 Smithkline Beecham Plc Novel compounds
ES2271967T3 (es) 1996-03-29 2007-04-16 Duphar International Research B.V Compuestos de piperazina y piperidina.
US6132538A (en) 1998-07-30 2000-10-17 Autoliv Development Ab High gas yield generant compositions
GB0012165D0 (en) 2000-05-20 2000-07-12 Team Consulting Ltd Portable device with consistent power output

Also Published As

Publication number Publication date
DE60002583T2 (de) 2004-03-25
JP2003506370A (ja) 2003-02-18
PT1204658E (pt) 2003-08-29
DK1204658T3 (da) 2003-09-01
CA2380531A1 (en) 2001-02-08
EP1204658B1 (de) 2003-05-07
ES2198329T3 (es) 2004-02-01
US6638936B1 (en) 2003-10-28
DE60002583D1 (de) 2003-06-12
WO2001009123A1 (en) 2001-02-08
AU6220300A (en) 2001-02-19
EP1204658A1 (de) 2002-05-15

Similar Documents

Publication Publication Date Title
NL300877I2 (nl) obeticholzuur
ATE297910T1 (de) Retinoid x rezeptormodulatoren
BR0114045A (pt) Poliarilcarboxamidas úteis como agentes redutores de lipìdeos
DK1204654T3 (da) Benzofurylpiperaziner og benzofurylhomopiperaziner: Serotonin agonister
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
DE60107449D1 (de) Substituierte aminopropoxyarylderivate als lxr agonisten
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
DE60121461D1 (de) Kondensierte pyridoindolderivate
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
EA200300619A1 (ru) Серотонинергические средства
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
DE60112960D1 (de) Kondensierte pyridoindolderivate
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
BR0208812A (pt) Derivados fenil heterociclil éter como inibidores de recaptação de serotonina
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
PT1204659E (pt) Benzofuranos serotoninergicos
ATE293111T1 (de) Kondensierte pyrazindionderivate als pde inhibitoren
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
DE60107832D1 (en) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
UA41350C2 (uk) Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі
DE60227113D1 (de) Kondensierte camptothecine als antitumormittel
ATE243695T1 (de) 5-bicycloindolverbindungen
ATE262521T1 (de) Pyrimidinyl methyl indolderivate mit antibakterieller wirkung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1204658

Country of ref document: EP

REN Ceased due to non-payment of the annual fee